We thus present our model of DUX4 expression as a theoretical setting to understand the complex dynamics of this important disease gene and as an open source, in silico platform to rapidly and cheaply pre-screen anti-DUX4 therapy for FSHD. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.